We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing ...

Research analysts at StockNews.com assumed coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research ...

(AP Photo/Gene J. Puskar) Supporters cheer as Republican Pennsylvania Senate candidate David McCormick speaks during an ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

Tanner Adell is a country girl with a pop diva heart. She loves Beyoncé, Cher and Blue Bell ice cream. She calls herself a ...

Donald Trump defeated Kamala Harris in the 2024 race for the White House. Follow along with live updates from across the USA ...

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

Sarepta Therapeutics is advancing SRP-9003 gene therapy for LGMD, with phase 3 study results expected in early 2025. Learn ...